Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials
Speaker
Prof. Charlotte Teunissen
Professor in Neurochemistry
Charlotte Teunissen’s drive is to improve the care of patients with neurological diseases by developing body fluid biomarkers for diagnosis, stratification, prognosis, and monitoring treatment responses.
Julius Clinical and Amsterdam UMC are proud to present the webinar:
Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials
During this webinar, Charlotte Teunissen, Professor in Neurochemistry at Amsterdam UMC touched upon:
- Patient selection
- Patient stratification
- Outcome measures
Related webinars
Webinar – Time to event trial designs in ALS: How useful are they?
LIVE WEBINAR | NOVEMBER 26 - 2024 | 17.00 CET Time to event trial designs in ALS: How useful are they? During the webinar hosted by Lieza Exalto, Ruben van Eijk, Lotte Smets and Jordi van Unnik will touch upon:An introduction to event-driv...
Webinar – Clinical consequences of the New MASLD Nomenclature
On the 27th of June, we organized the webinar: 'Clinical Consequences of the New MASLD Nomenclature' with guest speaker Prof. Maja Thiele.During this webinar, our speaker and hosts dived into the following topics:Is the MASLD nomeclature...
Webinar: Plasma biomarkers for diagnosis and monitoring of neurodegenerative disorders
On October 15, at 16.00 CEST, we presented the webinar:Plasma biomarkers for diagnosis and monitoring of neurodegenerative disordersTopics that are discussed:Plasma biomarkers, such as Amyloid, pTau and NfL. Treatment effect in ne...